Beihai Gofar Marine Biological Industry Co Ltd Total Liabilities
Beihai Gofar Marine Biological Industry Co Ltd total liabilities. Based on the latest financial reports, Beihai Gofar Marine Biological Industry Co Ltd (600538) has total liabilities worth CN¥187.93 Million CNY (≈ $27.50 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Beihai Gofar Marine Biological Industry to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Beihai Gofar Marine Biological Industry Co Ltd (1999–2025)
Total liabilities of Beihai Gofar Marine Biological Industry Co Ltd from 1999 to 2025. This chart illustrates how Beihai Gofar Marine Biological Industry Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Beihai Gofar Marine Biological Industry 's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Beihai Gofar Marine Biological Industry Co Ltd Competitors by Total Liabilities
The table below lists competitors of Beihai Gofar Marine Biological Industry Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Eightco Holdings Inc.
NASDAQ:ORBS
|
USA | $13.42 Million |
|
Norske Skog Asa
OL:NSKOG
|
Norway | Nkr8.29 Billion |
|
Enanta Pharmaceuticals Inc
NASDAQ:ENTA
|
USA | $195.80 Million |
|
Suzhou Yangtze New Materials
SHE:002652
|
China | CN¥218.87 Million |
|
Agencia Comercial Spirits Ltd Class A Ordinary Shares
NASDAQ:AGCC
|
USA | $18.35 Million |
|
Materialise NV
NASDAQ:MTLS
|
USA | $162.93 Million |
|
Eikon Therapeutics, Inc. Common Stock
NASDAQ:EIKN
|
USA | $313.07 Million |
|
Ningbo Color Master Batch Co. Ltd.
SHE:301019
|
China | CN¥120.45 Million |
Liability Composition Analysis (1999–2025)
This chart breaks down Beihai Gofar Marine Biological Industry Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 600538 total asset value.
Liquidity & Leverage Metrics
Beihai Gofar Marine Biological Industry Co Ltd Total Liabilities Ratios Explained
Beihai Gofar Marine Biological Industry Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beihai Gofar Marine Biological Industry Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beihai Gofar Marine Biological Industry Co Ltd (1999–2025)
The table below shows the annual total liabilities of Beihai Gofar Marine Biological Industry Co Ltd from 1999 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥196.03 Million ≈ $28.69 Million |
+9.30% |
| 2024-12-31 | CN¥179.36 Million ≈ $26.25 Million |
+1.78% |
| 2023-12-31 | CN¥176.22 Million ≈ $25.79 Million |
-3.27% |
| 2022-12-31 | CN¥182.17 Million ≈ $26.66 Million |
+13.74% |
| 2021-12-31 | CN¥160.16 Million ≈ $23.44 Million |
-25.21% |
| 2020-12-31 | CN¥214.15 Million ≈ $31.34 Million |
+105.05% |
| 2019-12-31 | CN¥104.44 Million ≈ $15.28 Million |
-16.99% |
| 2018-12-31 | CN¥125.82 Million ≈ $18.41 Million |
+7.01% |
| 2017-12-31 | CN¥117.57 Million ≈ $17.20 Million |
-56.28% |
| 2016-12-31 | CN¥268.93 Million ≈ $39.35 Million |
+9.24% |
| 2015-12-31 | CN¥246.18 Million ≈ $36.02 Million |
-5.88% |
| 2014-12-31 | CN¥261.57 Million ≈ $38.28 Million |
-54.84% |
| 2013-12-31 | CN¥579.21 Million ≈ $84.76 Million |
+10.88% |
| 2012-12-31 | CN¥522.38 Million ≈ $76.44 Million |
+3.46% |
| 2011-12-31 | CN¥504.93 Million ≈ $73.89 Million |
+4.91% |
| 2010-12-31 | CN¥481.29 Million ≈ $70.43 Million |
-34.61% |
| 2009-12-31 | CN¥736.06 Million ≈ $107.71 Million |
-16.53% |
| 2008-12-31 | CN¥881.78 Million ≈ $129.03 Million |
+8.15% |
| 2007-12-31 | CN¥815.31 Million ≈ $119.30 Million |
+5.65% |
| 2006-12-31 | CN¥771.73 Million ≈ $112.93 Million |
+7.73% |
| 2005-12-31 | CN¥716.35 Million ≈ $104.82 Million |
+36.96% |
| 2004-12-31 | CN¥523.05 Million ≈ $76.54 Million |
+100.14% |
| 2003-12-31 | CN¥261.34 Million ≈ $38.24 Million |
+198.04% |
| 2002-12-31 | CN¥87.69 Million ≈ $12.83 Million |
+14.61% |
| 2001-12-31 | CN¥76.51 Million ≈ $11.20 Million |
-15.46% |
| 2000-12-31 | CN¥90.50 Million ≈ $13.24 Million |
+33.42% |
| 1999-12-31 | CN¥67.83 Million ≈ $9.93 Million |
-- |
About Beihai Gofar Marine Biological Industry Co Ltd
Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, distributes pharmaceutical products in China. It operates through Pharmaceutical Distribution; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails pharmaceutical products through hospitals, clinics, other medical institutions, phar… Read more